Focus on Lung Cancer
Adjuvant Therapy is given after surgery to lower the risk of the lung cancer returning.
There are four basic ways to treat lung cancer: surgery, radiation therapy, chemotherapy, and targeted therapy. Your treatment will depend on several factors, including the type and stage of your cancer, possible side effects, and your preferences and overall health. In addition to these standard therapy options, you may also consider taking part in a clinical trial.
The U.S. Food and Drug Administration has approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test.
Different types of treatments are available for people with non-small cell lung cancer. Surgery, radiation therapy, chemotherapy, targeted therapy, laser therapy, photodynamic therapy, cryosurgery, electrocautery, and watchful waiting are the nine standard treatments used for this cancer.